X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.indianpharmapost.com/news/astrazeneca-completes-acquisition-of-gracell-15300
https://www.globenewswire.com//news-release/2024/02/20/2831733/0/en/Gracell-Biotechnologies-Announces-Shareholders-Approval-of-Merger-Agreement.html
https://www.globenewswire.com/news-release/2024/01/29/2818728/0/en/Gracell-Biotechnologies-Announces-FDA-Clearance-of-IND-Application-for-Phase-1-Clinical-Trial-of-FasTCAR-T-GC012F-as-Early-Line-Treatment-of-Multiple-Myeloma.html
https://www.astrazeneca.com/media-centre/press-releases/2023/astrazeneca-to-acquire-gracell-furthering-cell-therapy-ambition-across-oncology-and-autoimmune-diseases.html
https://www.globenewswire.com//news-release/2023/12/21/2799883/0/en/Gracell-Biotechnologies-Announces-China-NMPA-Clearance-for-IND-Application-for-Phase-1-2-Clinical-Trial-of-FasTCAR-T-GC012F-for-the-Treatment-of-Refractory-Systemic-Lupus-Erythemat.html
https://endpts.com/biotech-car-t-roundup-autolus-gracell-tout-early-stage-data-at-ash/
https://www.globenewswire.com//news-release/2023/12/12/2794331/0/en/Gracell-Biotechnologies-Presents-Updated-Clinical-Data-from-FasTCAR-T-GC012F-Demonstrating-Deep-and-Durable-Responses-in-Newly-Diagnosed-Multiple-Myeloma-at-ASH-2023.html
https://www.globenewswire.com//news-release/2023/11/27/2786133/0/en/Gracell-Biotechnologies-Announces-FDA-Clearance-of-IND-Application-for-Phase-1-2-Clinical-Trial-of-FasTCAR-T-GC012F-for-the-Treatment-of-Refractory-Systemic-Lupus-Erythematosus.html
https://www.globenewswire.com//news-release/2023/11/16/2781769/0/en/Gracell-Biotechnologies-to-Participate-in-Inaugural-Cell-Therapy-for-Autoimmune-Disease-Summit.html
https://www.globenewswire.com//news-release/2023/11/13/2778938/0/en/Gracell-Biotechnologies-Reports-Third-Quarter-2023-Unaudited-Financial-Results-and-Provides-Corporate-Update.html
Market Place
Share 
